Septerna (SEPN) Accumulated Depreciation (2023 - 2026)
Septerna's quarterly Accumulated Depreciation came in at $4.8 million in Q1 2026, up 43.51% year-on-year from $3.3 million in Q1 2025, and up 9.67% quarter-over-quarter from $4.4 million in Q4 2025.
Septerna has reported Accumulated Depreciation for 4 years, with the latest figure at $4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation rose 43.51% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 43.51% YoY), and the FY2025 full-year result was $4.4 million, up 48.58% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $4.8 million, up from $4.4 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $4.8 million in Q1 2026, with the low at $1.6 million in Q4 2023.
- Average Accumulated Depreciation over 4 years is $3.4 million, with a median of $3.5 million recorded in 2025.
- Year-over-year, Accumulated Depreciation jumped 80.58% in 2024 and soared 43.51% in 2026.
- Tracing SEPN's Accumulated Depreciation over 4 years: stood at $1.6 million in 2023, then jumped by 80.58% to $2.9 million in 2024, then soared by 48.58% to $4.4 million in 2025, then gained by 9.67% to $4.8 million in 2026.
- The last three Accumulated Depreciation figures came in at $4.8 million (Q1 2026), $4.4 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.77 Mn |
| Dec 31, 2025 | 4.35 Mn |
| Sep 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Dec 31, 2023 | 1.62 Mn |